HIP ATTACK-2
- Study HIC#:2000033954
- Last Updated:02/25/2025
A clinical trial to determine if accelerated medical clearance and surgery (with a goal of surgery within 6 hours of hip fracture diagnosis) compared to standard care will reduce the risk of death and other major health complications for patients with a hip fracture and an acute heart injury.
- Age45 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Edgar Benitez
- Phone Number: 1-203-393-6591
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Eligibility Criteria
INCLUSION CRITERIA – Must be YES to questions 1 - 4
- Age ≥45 years.
- Diagnosis of hip fracture during working hours with a low-energy mechanism requiring surgery.
- Troponin elevation (at least one troponin measurement above the upper limit of normal occurring from the time of hip fracture to the time of randomization); and
- Informed consent.
EXCLUSION CRITERIA – Must be NO to questions 1 – 7
- Taking a therapeutic - dose of an anticoagulant and accelerated surgery is not feasible, or there is no reversible agent available.
- Patients with peri-prosthetic fracture, open fracture or bilateral fractures.
- Patients requiring an emergency surgery for another reason (e.g., subdural hematoma).
- Patients with acute myocardial infarction clinically unstable, with a mechanical complication (i.e., acute papillary muscle rupture, ventricular septal defect), ST elevation myocardial infarction, or cardiogenic shock.
- Patients refusing consent; or
- Patients previously enrolled in HIP ATTACK-2.
